Latest News
Asia Pacific outbound merger and acquisition activity continues to accelerate, with more than USD275 billion of transactions announced in the last 18 months alone, according to a new report released today by Baird.
The report notes that Asia Pacific outbound M&A deal value is on a steep growth path, increasing 65 per cent in H1 2015 compared to H1 2014. Baird anticipates that both the number and the size of these transactions will continue to grow, with China increasingly challenging Japan as the leading acquirer of target companies based in North America and Europe. Japan’s outbound M&A activity peaked in 2012
AXA has invested in Eranove, a West African utility company with operations in power generation, transmission and distribution, as well as water production and distribution, acquiring a 18.6 per cent stake from Bouygues.
Eranove operates primarily in Ivory Coast and Senegal through concession companies including CIE, SODECI, SDE and an independent power producer, CIPREL.
In a context of accelerating private infrastructure investments, this long term investment to support the growth of Eranove would allow AXA to increase the exposure of its asset portfolio to the fast-growing African utilities sector and confirms the Group’s decision to increase its infrastructure investments
Wermuth Asset Management’s (WAM) Greater Europe Deep Value Fund SPV has exited it investment in National Recovery Service (NRS), a debt collection service provider based in Russia and Eastern Europe. The investment generated a return of 3.2x on capital invested and an IRR of 17 per cent.
NRS services 450 clients through its 72 offices across Eastern Europe. It currently employs over 1,500 professionals and operates four state-of-the-art call centres in Moscow, Novosibirsk, Volgograd and Kiev. Since 2006, NRS has recovered over 10 billion roubles for its clients, which include major Russian and international financial service institutions, telecoms and other
eEquity, a growth investor in Nordic Internet companies has held the first closing of its latest fund, eEquity III, at EUR60 million, supported by existing and new European Institutional investors
eEquity III will build on the investment strategy implemented in eEquity II, providing growth capital to proven, fast growing and profitable Nordic Internet companies active within the internet retail and services sectors.
eEquity works actively with its portfolio companies to support them in becoming Nordic market leaders by accelerating growth organically and via selective add-on acquisitions. The firm's approach to value creation was most recently demonstrated by the exit
Octopus Investments (Octopus) has launched a GBP50 million fundraise for the Octopus Titan Venture Capital Trust (Titan VCT).
With over GBP215 million in assets under management, Titan VCT is the largest VCT on the market and has a strong track record of delivering returns for investors. Since it was first launched in 2007 it has focused on investing into high growth early stage companies, backing talented management teams that have the potential to develop the successful businesses of tomorrow.
Today the VCT offers investors the opportunity to invest in a well-established and diverse portfolio of around 50 smaller companies.
Global venture capital firm New Enterprise Associates (NEA) has appointed Stephen Oesterle (pictured), MD, as Venture Partner. Dr Oesterle is a former Executive Vice President for Medtronic and brings to NEA more than two decades of experience spanning health technology investment, corporate strategy, and general management.
"Dr Oesterle is one of the most widely known and respected leaders in the medical device industry, and it is an honor to welcome him to the NEA team," says Dr Josh Makower, NEA General Partner and founder of several medical device companies. "Steve brings with him a vast global network of relationships across
Crestbridge in Luxembourg has enhanced its position as a provider of services to venture capital funds having received approval through Luxembourg’s regulator (CSSF) to act as a manager under the European Venture Capital Funds (EuVECA) regulation.
Already an authorised provider of both UCITS and AIFM services in Luxembourg, the new license means that Crestbridge is now one of only a handful of authorised firms across Europe able to provide management services to venture capital funds through its well established Management Company (ManCo) framework.
Crestbridge’s successful registration means it can act as manager for qualifying venture capital funds and distribute
Arthur J Gallagher has enhanced its liability and crime insurance solution for investment managers IMI Pro to provide its broadest cover yet.
The Gallagher-designed policy, backed by ‘A+’ rated capacity, responds to the needs of managers and funds by covering personal liability, civil liability and crime in one comprehensive package exclusive to Gallagher clients.
Notable enhancements include:
Full limit mitigation cover — insureds can take mitigating action immediately, without obtaining insurers’ prior consent, to the full limit of the policy. This will cover payments made and costs incurred in seeking to avoid claims that would be covered under
The Lyxor Hedge Fund Index was down -2.7% in August. One out of 12 Lyxor Indices ended the month in positive territory. The Lyxor Convertible Arbitrage Index (+3.3%), the Lyxor L/S Equity Variable Bias Index (-0.7%), and the Lyxor L/S Equity Market Neutral Index (-1.1%) were the best performers.
The deflation and growth scares, which built up over the summer, accelerated following the CNY devaluation. They morphed into a vicious cycle in the last week of August. With volatility reaching 55 and equities plunging by the hour, Monday 24 will from now on count among the major stress episodes used as
Delphinus Medical Technologies has secured a venture round of USD39.5 million.
Led by Venture Investors, the Series C round included new investment from Hopen Life Science Ventures and Waycross Ventures along with current investors Arboretum Ventures, Beringea, and North Coast Technology Investors. The oversubscribed financing round will be used to underwrite regulatory efforts and fuel the commercialisation plans for SoftVue, Delphinus’ breakthrough whole breast ultrasound system that allows physicians to image the entire breast, including the chest wall, for diagnostic imaging purposes.
“Delphinus has the potential to have a profound impact on the effectiveness of breast cancer screening for
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
